The affirmation and assignment are based on several factors, including the health system’s leading market position, robust partnership strategy, good liquidity metrics and solid management team.
“The outlook revision reflects our view of PeaceHealth’s improved operations over the last two fiscal years, following operating losses in fiscal 2016,” said S&P credit analyst Allison Bretz.
More articles on healthcare finance:
CMS miscalculated MIPS payment adjustments: 4 things to know
Memorial Sloan Kettering shifts fundraising focus as problems mount
CHS could face cash crunch after $262M settlement, Moody’s warns
